These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7913658)

  • 1. Verapamil-reversing concentrations induce blood flow changes that could counteract in vivo the MDR-1-modulating effects.
    Ramirez LH; Munck JN; Zhao Z; Bognel C; Ricard M; Ardouin P; Rougier P; Gouyette A
    Cancer; 1994 Aug; 74(3):810-6. PubMed ID: 7913658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil and degradable starch microspheres during hepatic artery infusion of doxorubicin.
    Thom AK; Zhang SZ; Deveney C; Daly JM
    Surgery; 1990 May; 107(5):552-9. PubMed ID: 2333595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of cytotoxicity of doxorubicin by verapamil in the hepatic artery infusion for liver tumors in rats.
    Miyazaki M; Shimoda T; Itoh H; Kaiho T; Iinuma K; Koyama T; Nakagawa K; Andoh K; Anbiru S; Ohtawa S
    Cancer; 1993 Jul; 72(2):349-54. PubMed ID: 8319168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion.
    Ridge JA; Collin C; Bading JR; Hancock C; Conti PS; Daly JM; Raaf JH
    Cancer Res; 1988 Aug; 48(16):4584-7. PubMed ID: 3396009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of doxorubicin uptake by epinephrine in the VX-2 carcinoma.
    Thom AK; Sigurdson ER; Ridge JA; Zhang SZ; Daly JM
    J Surg Res; 1987 May; 42(5):543-9. PubMed ID: 3586624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhancement of anti-tumor effect of adriamycin by verapamil in a hepatic arterial infusion in the rats: preliminary report].
    Shimoda T; Miyazaki M; Utagawa I; Koshikawa H; Ito H; Suzuki H; Okui K
    Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):226. PubMed ID: 2038296
    [No Abstract]   [Full Text] [Related]  

  • 7. A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance.
    Saltz L; Murphy B; Kemeny N; Bertino J; Tong W; Keefe D; Tzy-Jun Y; Tao Y; Kelsen D; O'Brien JP
    Cancer; 1994 Nov; 74(10):2757-64. PubMed ID: 7954234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transcatheter intraarterial therapies on the distribution of Doxorubicin in liver cancer in a rabbit model.
    Liang B; Xiong F; Wu H; Wang Y; Dong X; Cheng S; Feng G; Zhou G; Xiong B; Liang H; Xia X; Zheng C
    PLoS One; 2013; 8(10):e76388. PubMed ID: 24116106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
    Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
    Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
    Schuurhuis GJ; van Heijningen TH; Cervantes A; Pinedo HM; de Lange JH; Keizer HG; Broxterman HJ; Baak JP; Lankelma J
    Br J Cancer; 1993 Nov; 68(5):898-908. PubMed ID: 8105865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial infusion of verapamil and doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration: pharmacological evaluation of reduction in systemic drug exposure and assessment of hepatic toxicity.
    Fuhrman GM; Cromeens DM; Newman RA; Cleary KR; Carrasco CH; Wright KC; Guercio S; Guercio A; Curley SA
    Surg Oncol; 1994 Feb; 3(1):17-25. PubMed ID: 8186867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
    Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
    J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does combined single intravenous injection of doxorubicin and verapamil have any influence on hemodynamic parameters in rabbits?
    Stepień M; Drzewoski J
    Mater Med Pol; 1995; 27(1):19-22. PubMed ID: 8569271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I and pharmacokinetic study of D-verapamil and doxorubicin.
    Bissett D; Kerr DJ; Cassidy J; Meredith P; Traugott U; Kaye SB
    Br J Cancer; 1991 Dec; 64(6):1168-71. PubMed ID: 1684909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
    Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
    Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein regulates chemosensitivity in early developmental stages of the mouse.
    Elbling L; Berger W; Rehberger A; Waldhör T; Micksche M
    FASEB J; 1993 Dec; 7(15):1499-506. PubMed ID: 7903262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in hepatic blood flow during transcatheter arterial infusion with heated saline in hepatic VX2 tumor.
    Cao W; Li J; Wu ZQ; Zhou CX; Liu X; Wan Y; Duan YY
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):764-72. PubMed ID: 22869046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres.
    Liu Z; Ballinger JR; Rauth AM; Bendayan R; Wu XY
    J Pharm Pharmacol; 2003 Aug; 55(8):1063-73. PubMed ID: 12956895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of a synthetic lipid A derivative, DT-5461a, reduces tumor blood flow through endogenous TNF production in hepatic cancer model of VX2 carcinoma in rabbits.
    Jimbo T; Akimoto T; Tohgo A
    Anticancer Res; 1996; 16(1):359-64. PubMed ID: 8615636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive expression of functional P-glycoprotein in rat hepatoma cells.
    Fardel O; Loyer P; Lecureur V; Glaise D; Guillouzo A
    Eur J Biochem; 1994 Jan; 219(1-2):521-8. PubMed ID: 7905826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.